-
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
Analysis of Clinical and Economic Evidence Focused on RWE in Medicare Drug Price Negotiations: Sacubitril/Valsartan, Rivaroxaban, and Apixaban
Sep 9, 2025, 16:22 PM -
Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
Treatment Effect Extrapolation Assumptions in NICE Highly Specialized Technology Appraisals
Sep 9, 2025, 16:22 PM -
COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States
Sep 9, 2025, 16:22 PM -
Spinal Muscular Atrophy Treatments in France: What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations
Sep 9, 2025, 16:22 PM -
A Contemporary Approach to Determining Cancer Patients Healthcare Resources Utilization
Sep 9, 2025, 16:22 PM -
Standardizing Healthtech Evidence to Meet NICE Expectations
Sep 9, 2025, 16:22 PM -
Involving Women With Lived Experience of Pelvic Organ Prolapse in Designing and Refining the Economic Components of a Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity TB1 SY2 Costs Due to Premature Cancer-Related Mortality in Morocco
Sep 9, 2025, 16:22 PM -
Cardiovascular Disease Risk-Reducing Strategies in Qatari Diabetes Patients: A Cost-Effectiveness Study
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Economic Burden Among Caregivers of Individuals With Autism Spectrum Disorder Caregiver: Findings From the 2024 5EU National Health and Wellness Survey
Sep 9, 2025, 16:22 PM -
A Review of Indirect Costs Within Economic Appraisals in France
Sep 9, 2025, 16:22 PM -
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Osteoarthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM -
Durable Medical Equipment and Ancillary Service Use in Rett Syndrome Management: A Global Comprehensive Review of Literature
Sep 9, 2025, 16:22 PM -
Development of a Markov Model-Based Visualization Tool of Regional HPV Vaccination Coverage Rates Over Time in Austria: Combining Data From Pharmaceutical Industry and Healthcare Data Including National Vaccination Registry
Sep 9, 2025, 16:22 PM -
Estimation of Utility Weights for Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Previously Treated with a Covalent Bruton Kinase Inhibitor (cBTKi)
Sep 9, 2025, 16:22 PM -
Barriers and Facilitators Influencing the Development of Complex Generics: An Exploratory Study
Sep 9, 2025, 16:22 PM -
Early Impact of the Mazars Review on Reimbursement Timelines in Ireland
Sep 9, 2025, 16:22 PM -
Cost Impact of the Porcine Urinary Bladder Matrix in Patients With Diabetic Foot Ulcer in the United Kingdom
Sep 9, 2025, 16:22 PM
